台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    45.85
  • 漲跌
    ▲0.45
  • 漲幅
    +0.99%
  • 成交量
    122
  • 產業
    上市 生技醫療類股
  • 126人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
和康生 (1783)籌碼相關-元富 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0404/2005/0405/1805/3006/0806/2207/0407/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1212/2001/0201/1001/2202/1002/1803/1003/1802/2642.54547.55052.55557.5May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元富 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/1700.006246.1545.40-62344-17.98%
2025/03/12148.154148.8048.40-40339-11.80%
2025/03/11449.4900.0049.5043361.19%
2025/03/101050.5000.0050.40103352.98%
2025/03/072950.0300.0050.20293348.68%
2025/03/06049.55151.1050.90-1331-0.30%
2025/03/05750.2400.0049.6073242.16%
2025/03/04554.30154.6053.7043021.32%
2025/03/03153.20153.0053.0002970.00%
2025/02/2700.00752.8152.70-7286-2.45%
2025/02/13249.8000.0049.4522710.74%
2025/02/11150.8000.0050.4012720.37%
2025/02/1000.00251.7551.60-2268-0.75%
2025/02/07250.1000.0050.5022630.76%
2025/02/0500.002447.6647.65-24248-9.65%
2025/02/04249.10349.0048.60-1242-0.41%
2025/02/0300.003050.2750.70-30238-12.59%
2025/01/22050.2000.0050.3002350.00%
2025/01/20250.4000.0051.2022320.86%
2025/01/1600.0010.549.7951.00-10.5226-4.64%
2025/01/1400.00252.2052.10-2211-0.94%
2025/01/1000.00152.9051.70-1198-0.50%
2025/01/095752.1800.0052.305719029.86%
2025/01/08151.8000.0051.7011840.54%
2025/01/0700.00152.9052.10-1176-0.57%
2025/01/061851.1400.0050.801815911.30%
2025/01/0300.00150.5050.10-1146-0.68%
2024/12/304049.3700.0048.854013729.07%
2024/12/19046.3200.0046.3001280.00%
2024/11/08843.7000.0043.8081206.64%
2024/10/0900.00043.0043.2002240.00%
2024/09/3000.00042.3042.7002720.00%
2024/09/1300.00044.5544.2003970.00%
2024/09/0600.002245.2745.50-22406-5.41%
2024/09/0200.00046.5546.5504140.00%
2024/08/2600.00045.9546.1004300.00%
2024/08/232245.8600.0046.10224295.12%
2024/08/2200.00245.6045.60-2429-0.47%
2024/08/13042.9500.0043.1004250.00%
2024/08/07040.4500.0040.8504180.00%
2024/07/26144.3000.0044.3013960.25%
2024/07/23245.45245.5545.5503930.00%
2024/07/22145.7500.0046.5013910.26%
2024/07/1800.00147.9548.00-1346-0.29%
2024/07/11145.0500.0045.0013290.30%
2024/07/0800.00147.3547.00-1311-0.32%
2024/07/03150.50450.5050.40-3284-1.05%
2024/06/1800.00046.5046.350165-0.01%
2024/06/1400.00044.2544.250157-0.01%
2024/06/07145.50145.5545.6001550.00%
2024/05/1000.00343.3243.40-3155-1.93%
2024/05/0300.00043.0542.9001540.00%
2024/04/26442.55842.3642.25-4155-2.57%
2024/04/22342.3500.0042.3531631.83%
2024/04/18143.90144.1043.9501580.00%
2024/04/16144.55143.3543.3501610.00%
2024/04/15145.05144.5544.5501600.00%
2024/04/01246.5000.0046.5521661.20%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章